Home » Authors » Jennifer Boggs

Articles by Jennifer Boggs

QLT's BPH drug doesn't show efficacy in Phase II study

Feb. 21, 2006

By Jennifer Boggs

QLT’s BPH Drug Fails To Show Efficacy In Phase II

Feb. 17, 2006

By Jennifer Boggs

QLT’s BPH Drug Fails To Show Efficacy In Phase II

Feb. 17, 2006

By Jennifer Boggs

Australia’s G2 Enters Novo Deal Valued At Up To $102M

Feb. 16, 2006

By Jennifer Boggs

Australia’s G2 Enters Novo Deal Valued At Up To $102M

Feb. 16, 2006

By Jennifer Boggs

YM’s Direct Offering Raises $40M For Drug Development

Feb. 15, 2006

By Jennifer Boggs

YM’s Direct Offering Raises $40M For Drug Development

Feb. 15, 2006

By Jennifer Boggs

Replidyne Gets $50M Up Front Through Forest Collaboration

Feb. 14, 2006

By Jennifer Boggs

Replidyne Gets $50M Up Front Through Forest Collaboration

Feb. 14, 2006

By Jennifer Boggs

After First Product Approval, BioMimetic Seeks $50M IPO

Feb. 13, 2006

By Jennifer Boggs